Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.9B | 4.2B | 4.3B | 4.2B |
| Cost of revenue | 2.0B | 2.1B | 2.2B | 2.1B |
| Gross profit | 1.9B | 2.1B | 2.1B | 2.0B |
| Operating expense | ||||
| Research & development | 247M | 247M | 240M | 269M |
| Selling general and admin | 919M | 952M | 924M | 939M |
| Other operating expenses | 5M | — | — | — |
| Operating income | 706M | 922M | 984M | 816M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 225M | 239M | 272M | 241M |
| Other income expense | -186M | -882M | -1.0B | -822M |
| Pretax income | 294M | -247M | -324M | -246M |
| Tax provision | 74M | 28M | 69M | 630M |
| Net income | 220M | -275M | -390M | -874M |
| Basic EPS | 0.2 | -0.2 | -0.4 | -0.8 |
| Diluted EPS | 0.2 | -0.2 | -0.4 | -0.8 |
| Basic average shares | 1.1B | 1.1B | 1.1B | 1.1B |
| Diluted average shares | 1.2B | 1.1B | 1.1B | 1.1B |
| EBITDA | 951M | 1.1B | 1.3B | 1.1B |
| Net income from continuing op. | 220M | -275M | -390M | -874M |
| Minority interests | -6M | 58M | -47M | 29M |
| Preferred stock dividends | — | — | — | — |